Biology Reference
In-Depth Information
67. Jiang M, Ryu J, Kiraly M, Duke K, Reinke V, Kim SK. Genome-wide analysis of
developmental and sex-regulated gene expression profiles in
Caenorhabditis elegans
.
Proc
Natl Acad Sci USA
2001;98:218
23.
68. Cantacessi C, Jex AR, Hall RS, Young ND, Campbell BE, Joachim A, et al. A practical,
bioinformatic workflow system for large data sets generated by next-generation
sequencing.
Nucleic Acids Res
2010;38. e171.
69. Campbell BE, Nagaraj SH, Hu M, Zhong W, Sternberg PW, Ong EK, et al. Gender-
enriched transcripts in
Haemonchus contortus
e
predicted functions and genetic inter-
actions based on comparative analyses with
Caenorhabditis elegans
.
Int J Parasitol
2008;38:65
e
83.
70. Hu PJ. Dauer.
WormBook
2007:1
e
19.
71. Campbell BE, Boag PR, Hofmann A, Cantacessi C, Wang CK, Taylor P, et al. Atypical
(RIO) protein kinases from
Haemonchus contortus
e
e
promise as new targets for nema-
tocidal drugs.
Biotechnol Adv
2011;29:338
e
50.
72. Cohen P. Protein kinases
e
the major drug targets of the twenty-first century?
Nat Rev
15.
73. Campbell BE, Hofmann A, McCluskey A, Gasser RB. Serine/threonine phosphatases in
socioeconomically important parasitic nematodes
Drug Discov
2002;1:309
e
e
prospects as novel drug targets?
39.
74. Renslo AR, McKerrow JH. Drug discovery and development for neglected parasitic
diseases.
Nat Chem Biol
2006;2:701
Biotechnol Adv
2011;29:28
e
10.
75. Campbell BE, Tarleton M, Gordon CP, Sakoff JA, Gilbert J, McClusky A, et al. Nor-
cantharidin analogues with nematocidal activity in
Haemonchus contortus
.
Bioorg Med
Chem Lett
2011;21:3277
e
81.
76. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: conserved structure
and molecular mechanism.
Nature
1991;349:117
e
27.
77. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and
molecular mechanisms.
Nat Rev Immunol
2003;3:733
e
e
44.
78. Roberts A, Pimentel H, Trapnell C, Pachter L. Identification of novel transcripts in
annotated genomes using RNA-Seq.
Bioinformatics
2011;27:2325
9.
79. Zhong W, Sternberg PW. Genome-wide prediction of
C. elegans
genetic interactions.
Science
2006;311:1481
e
4.
80. Geenen PL, Bresciani J, Boes J, Pedersen A, Eriksen L, Fagerholm HP, et al. The
morphogenesis of
Ascaris suum
to the infective third-stage larvae within the egg.
J
Parasitol
1999;85:616
e
22.
81. Bargmann CI. Chemosensation in C.
elegans
. In: Community TCeR, editor.
Wormbook:
Wormbook
; October 25, 2006.
82. WHO.
Deworming for Health and Development
. Geneva: World Health Organization; 2005.
83. Montresor A, Zin TT, Padmasiri E, Allen H, Savioli L. Soil-transmitted helminthiasis in
Myanmar and approximate costs for countrywide control.
Trop Med Int Health
2004;
9:1012
e
5.
84. Jex AR, Lim YA, Bethony JM, Hotez PJ, Young ND, Gasser RB. Soil-transmitted
helminths of humans in Southeast Asia-towards integrated control.
Adv Parasitol
2011;74:
231
e
65.
85. Harder A, Schmitt-Wrede HP, Krucken J, Marinovski P, Wunderlich F, Willson J, et al.
Cyclooctadepsipeptides
e
an anthelmintically active class of compounds exhibiting
a novel mode of action.
Int J Antimicrob Agents
2003;22:318
e
31.
86. Geary TG, Woo K, McCarthy JS, Mackenzie CD, Horton J, Prichard RK, et al. Unre-
solved issues in anthelmintic pharmacology for helminthiases of humans.
Int J Parasitol
2010;40:1
e
13.
87. Keiser J, Utzinger J. The drugs we have and the drugs we need against major helminth
infections.
Adv Parasitol
2010;73:197
e
e
230.
